Tag: ukri new funding model

  • BA/Leverhulme Small Research Grants: Field Guide

    BA/Leverhulme Small Research Grants are a British Academy/Leverhulme Trust funding scheme offering up to £10,000 over one to 24 months to postdoctoral scholars, including independent scholars, ordinarily resident in the UK. Unlike most UKRI council grants, the scheme sits outside the Full Economic Costing (fEC) regime and is administered through the British Academy’s own Flexi-Grant portal, not the UKRI Funding Service.

    The British Academy/Leverhulme Small Research Grants scheme is one of the British Academy’s highest-volume programmes, making awards to academics working at around 100 institutions across the UK. It is funded as a public-private partnership between the Department for Science, Innovation and Technology (DSIT), the Leverhulme Trust and the Wellcome Trust, alongside several named Special Funds. For humanities and social science researchers who sit outside the large UKRI research councils, it is one of the few nationally competitive routes to discrete, project-defined funding.

    This guide sets out who can apply, what the money can and cannot be spent on, how reporting works, and — critically — how the scheme’s rules diverge from EPSRC, MRC and the wider UKRI funding architecture.

    What are the BA/Leverhulme Small Research Grants?

    The BA/Leverhulme Small Research Grants scheme is a competitive award covering the direct expenses of a clearly defined humanities or social science research project. Awards are worth up to £10,000 and are tenable for between one and 24 months, with a minimum award of £500 for a discrete, identifiable piece of work.

    According to the British Academy’s own scheme guidance, funding is intended to cover initial project planning and development, direct research costs such as travel, subsistence and specialist research assistance, and the advancement of research through workshops, conferences or visits to and from partner scholars. It is explicitly not a personal fellowship or salary-replacement scheme.

    Who is eligible to apply?

    Eligibility is narrower than many applicants assume, but it is also more open in one important respect: independent scholars are welcome.

    • Applicants must be postdoctoral scholars or equivalent and ordinarily resident in the United Kingdom.
    • Applications need the approval of the applicant’s employing institution where one exists, but are not restricted to a particular grade (Lecturer, Professor or otherwise).
    • Independent scholars without an institutional affiliation may apply directly, selecting “independent scholar” in the Flexi-Grant portal.
    • Co-applicants may be based anywhere in the world, provided the Principal Applicant is ordinarily resident in the UK.
    • Postgraduate students are not eligible — this is a postdoctoral-and-above scheme.

    From the 2026 application round, the British Academy introduced a distinct submission window for independent scholars, who must now submit at least five working days before the round closing date; late submissions in this category are not processed. This is a genuine procedural detail that trips up first-time independent applicants, who often assume the standard deadline applies to them.

    What can the budget cover — and what is excluded?

    Because the scheme sits outside UKRI’s Full Economic Costing framework, the budget rules are simpler than a typical research council application, but also more restrictive in specific ways.

    Allowed Not allowed
    Travel and subsistence for fieldwork or archive visits Replacement teaching costs
    Specialist research assistance Payment in lieu of salary
    Workshop, conference and collaboration costs tied to the funded project Computer equipment/hardware
    Project planning and development costs Attendance-only conference fees with no defined research objective

    Applications purely to organise or attend a third-party conference — the kind of activity once covered by the Academy’s discontinued Conference Support Grant and Overseas Conference Grant schemes — will not be considered unless directly tied to disseminating results from the funded project. Grants are also not intended to fund UK–overseas scholarly interchange where there is no defined programme of activity behind it.

    How does reporting and compliance work?

    Reporting obligations scale with the size and simplicity of the award rather than mirroring the multi-year monitoring cycle of a UKRI standard grant. Award-holders submit progress and financial reporting through Flexi-Grant, and extensions to the tenure of an award (up to the 24-month ceiling) can be requested for a defined set of reasons set out in the British Academy’s current guidance for grant-holders.

    Because the £10,000 ceiling is a direct-cost allocation to the award-holder rather than an institutional fEC award, host institutions typically have a lighter administrative burden than for a UKRI grant — there is no 20% institutional contribution to manage, and no Je-S or UKRI Funding Service record to maintain. This is a material difference for research administration teams that otherwise triage every award through the same fEC costing workflow.

    How does this compare with EPSRC, MRC and the UKRI new funding model?

    Researchers moving between disciplines often assume every UK grant sits inside the same UKRI application and costing system. BA/Leverhulme Small Research Grants are a useful case study in why that assumption fails.

    Feature BA/Leverhulme Small Research Grants EPSRC (UKRI) MRC (UKRI)
    Administering body British Academy (with Leverhulme Trust, DSIT, Wellcome Trust) UK Research and Innovation UK Research and Innovation
    Application portal Flexi-Grant (British Academy’s own system) UKRI Funding Service UKRI Funding Service
    Typical award scale Up to £10,000, direct costs only Responsive-mode/standard grants, typically far larger Responsive-mode/standard grants, typically far larger
    Full Economic Costing (fEC) Not covered by fEC — award is direct-cost only fEC applies; UKRI funds 80% of the Full Economic Cost, institution covers the remainder fEC applies; UKRI funds 80% of the Full Economic Cost, institution covers the remainder
    Independent scholar eligible Yes, with a dedicated submission window Generally requires an eligible host institution Generally requires an eligible host institution

    UKRI’s own reform programme — often referred to informally as the UKRI new funding model — has spent recent years consolidating research council applications onto the single UKRI Funding Service (replacing the legacy Joint Electronic Submission, or Je-S, system) and harmonising grant terms and conditions across councils. BA/Leverhulme Small Research Grants sit deliberately outside this consolidation: they are not migrating to the UKRI Funding Service, and they retain the Academy’s own Flexi-Grant portal and a distinct, non-fEC costing model. For research administrators building a single institutional workflow across funders, that is the single most consequential operational fact in this comparison.

    Answer-first Q&A

    How much can a BA/Leverhulme Small Research Grant cover?

    Awards run from a minimum of £500 up to a maximum of £10,000, tenable for between one and 24 months. The award funds a single, clearly defined piece of research with an identifiable outcome, not an open-ended programme of work or a personal fellowship.

    Who is eligible for BA/Leverhulme Small Research Grants?

    Postdoctoral scholars or equivalent who are ordinarily resident in the UK, including independent scholars without institutional affiliation. Co-applicants can be based anywhere, but the Principal Applicant must be UK-resident, and postgraduate students are not eligible.

    Are BA/Leverhulme Small Research Grants covered by Full Economic Costing?

    No. The scheme is explicitly outside the fEC regime that governs most UKRI research council grants. The £10,000 ceiling is a direct-cost award to the researcher, not an institutional fEC settlement, which removes the usual 80/20 UKRI-institution cost split entirely.

    What can BA/Leverhulme Small Research Grant funding not be used for?

    Funds cannot cover replacement teaching, payment in lieu of salary, or computer equipment. Grants also exclude stand-alone conference attendance or UK–overseas interchange that lacks a defined research objective tied to the funded project.

    Implications for humanities and social science applicants

    The practical takeaway for applicants and research administration offices is that BA/Leverhulme Small Research Grants require a genuinely different compliance checklist from an EPSRC or MRC application. Institutions whose research administration workflows route every funder through the same fEC costing template risk misclassifying this scheme — either by over-costing an award that is meant to be direct-cost only, or by missing the independent-scholar submission window introduced for the 2026 round.

    As UKRI consolidates research council funding onto a single portal and cost model, schemes like BA/Leverhulme Small Research Grants remain a deliberate exception — and, for humanities and social science researchers, an opportunity: a low-friction, direct-cost route to project funding that never touches the UKRI Funding Service. Teams that keep a funder-specific map of eligibility, costing and reporting rules, rather than one generic template, turn that simplicity into an advantage rather than a compliance gap.

  • MRC Funding Update UKRI: Grants Reopened

    MRC funding update, in brief: the Medical Research Council paused several applicant-led grant schemes from February 2026 while UK Research and Innovation restructured to an “always open” application model; research grants, new investigator grants and partnership grants reopened on 7 April 2026, experimental medicine opportunities reopened on 30 April 2026, and MRC Proof of Concept and Impact Acceleration Awards are scheduled to reopen in July 2026. For grant holders, the practical implications are a new rolling submission window, a consolidated review structure, and firm caps on how many applications one person can lead at once.

    The MRC funding update ukri has published since February 2026 marks the most significant procedural change to Medical Research Council grant administration in over a decade. Medical Research Council (MRC) is one of UK Research and Innovation’s seven disciplinary councils, responsible for funding biomedical and health research across the UK’s higher education and institute sector. This briefing sets out exactly what changed, what remains open, and what research administrators and principal investigators need to do differently when planning 2026 applications.

    What actually changed in the MRC funding update

    On 1 February 2026, UKRI Chief Executive Ian Chapman issued an open letter to the research and innovation community announcing a new investment approach for the 2026–2030 spending review period. The letter described a shift toward a “more strategic, UKRI-wide model” for funding decisions, and confirmed that MRC would use the transition to refresh its approach to applicant-led funding.

    The headline structural change is a move to an “always open” responsive-mode system, replacing fixed application deadlines. UKRI states that published deadlines “cause significant variation in the volume of applications we receive and in reviewer availability,” and that removing them smooths these peaks and troughs. This is an operating-model change, not a funding cut — MRC says curiosity-driven research remains a committed priority, underpinned by a UKRI-wide 50% budget commitment to that category of research.

    To implement the “always open” system, MRC had to pause several applicant-led funding opportunities from February 2026 while the assessment infrastructure was rebuilt. Awards that had already been offered, accepted or started were explicitly unaffected throughout the transition.

    Reopening timeline: what’s open now and what’s still paused

    As of the most recent UKRI update (15 June 2026), most MRC applicant-led schemes have reopened. Grant holders should treat the table below as the operative reference, not the earlier February pause notice, which is now superseded.

    MRC funding opportunity Status Reopening date
    Applicant-led research grants Open 7 April 2026
    New investigator research grants Open 7 April 2026
    Partnership grants (applicant-led) Open 7 April 2026
    Experimental medicine opportunities Open 30 April 2026
    MRC Proof of Concept (formerly Developmental Pathway Funding Scheme, stage one) Reopening July 2026
    MRC Impact Acceleration Awards (formerly MRC Gap Fund) Reopening July 2026
    Fellowships, studentships, Centres of Research Excellence Never paused Continuously open

    UKRI expects the wider transition to be complete by the start of the 2027–2028 financial year (6 April 2027 to 5 April 2028). Institutions running internal peer-review or costing pipelines timed to the old deadline calendar should recalibrate now: under “always open” mode, there is no annual cycle to plan around.

    The new College of Experts review structure

    MRC’s four disciplinary research boards — covering infections and immunity, molecular and cellular medicine, neurosciences and mental health, and population and systems medicine — have been consolidated into a single College of Experts. Funding panels are now drawn flexibly from this combined pool rather than fixed to a single board.

    This restructuring supports cross-disciplinary applications that previously sat awkwardly between boards, and enables faster decisions by decoupling panel composition from a rigid quarterly schedule. Applications closed before the transition — including the legacy boards’ November 2025 round and Developmental Pathway Funding Scheme stage two — are still assessed under the old structure, with decisions expected in April 2026; MRC has confirmed a reduced number of awards from that backlog, reflecting the changeover rather than any change in typical grant size going forward.

    Application caps and resubmission rules grant holders must know

    Two new eligibility mechanics apply under the “always open” model and directly affect how principal investigators should sequence their applications:

    • Application cap: a maximum of two applications as project lead may be submitted across applicant-led responsive-mode funding calls within any rolling 12-month period.
    • Resubmission bar: an application previously unsuccessful with MRC — or with any other funder — will not be considered again for 12 months, unless MRC has explicitly invited a resubmission.
    • Cost basis unchanged: MRC continues to fund 80% of the full economic cost (FEC), with grant durations ranging from 18 months to five years and no fixed cap on requested amount, provided the sum is proportionate to project scope.

    For research offices, “always open” does not mean unlimited throughput per investigator — it shifts the constraint from a calendar deadline to a rolling personal quota. Grant-writing capacity planning built around a fixed autumn or spring deadline now needs continuous tracking of each investigator’s rolling 12-month application count.

    Budget signals: what the wider UKRI settlement means

    UKRI has stated that its overall research and innovation budget is rising across the 2026–2030 spending review period, and that the budget for biomedical and health research specifically is “in an excellent position.” Independent analysis from the Campaign for Science and Engineering notes that the overall UKRI budget is set to rise toward £10 billion a year by 2030, though how that funding is distributed across councils and themes is shifting considerably as part of the same restructuring.

    A parallel strand channels additional funding through the UKRI Life Sciences Priority Programme — a cross-council theme through which MRC accesses coordinated funding beyond its standalone curiosity-driven allocation. UKRI frames this as additive: fellowships, studentships and Centres of Research Excellence funding was unaffected throughout, and the pause applied only to specific applicant-led schemes during infrastructure changes.

    BBSRC underwent the same “always open” transition in parallel; its new investigator award and standard research grant have also reopened. Grant holders working across MRC and BBSRC funding lines should expect the same rolling-quota and resubmission mechanics on both councils, since the operating model is shared across the UKRI-wide transition rather than council-specific.

    Frequently asked questions

    Why did MRC pause its funding opportunities in 2026?

    MRC paused several applicant-led schemes from February 2026 to implement UKRI’s move to an “always open” application system. UKRI stated that fixed deadlines caused uneven application volumes and reviewer availability problems, and that removing them required behind-the-scenes changes to assessment infrastructure before reopening.

    Which MRC grants have reopened?

    Applicant-led research grants, new investigator research grants and partnership grants reopened on 7 April 2026, and experimental medicine opportunities reopened on 30 April 2026. MRC Proof of Concept and MRC Impact Acceleration Awards are scheduled to reopen in July 2026.

    Were MRC fellowships and studentships affected?

    No. MRC has confirmed that funding for fellowships, studentships, and MRC Centres of Research Excellence was not affected by the 2026 pause and remained continuously open for applications throughout the transition period.

    How many MRC applications can one person lead at once?

    Under the new rules, a principal investigator may lead a maximum of two applications across applicant-led responsive-mode funding calls within any rolling 12-month period, and unsuccessful applications face a 12-month resubmission bar unless MRC has invited one.

    Implications for institutions and grant holders

    Research offices should update three things now. First, replace deadline-driven internal sign-off calendars with continuous submission tracking, since “always open” removes the predictable peaks institutions have historically planned costing and QA cycles around. Second, build a per-investigator rolling application count into grants-management systems to enforce the two-applications-per-12-months cap before a proposal reaches MRC and is rejected on eligibility grounds. Third, brief investigators explicitly on the 12-month resubmission bar — a previously unsuccessful proposal, even a strong one, is not eligible for quick resubmission without an explicit MRC invitation, which changes revision strategy considerably.

    MRC has said it will continue to share updates and reopen remaining funding opportunities as they become ready, with full transition to the new model expected by April 2027. Institutions with active or upcoming submissions should monitor the MRC application timeline directly rather than relying on the February 2026 pause notice, which the June 2026 update has substantially superseded.